182287-49-6 Usage
Uses
Used in Pharmaceutical Synthesis:
TERT-BUTOXYCARBONYLAMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID is used as a key intermediate for the synthesis of various drug candidates. Its Boc protecting group allows for the selective protection of functional groups, facilitating the creation of complex organic molecules with precise structural control.
Used in Organic Chemistry Research:
In the field of organic chemistry, TERT-BUTOXYCARBONYLAMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID is used as a building block for the development of new synthetic methodologies. Its unique structure and reactivity enable chemists to explore novel reaction pathways and strategies, potentially leading to more efficient and innovative synthetic processes.
Used in Bioactive Compound Development:
TERT-BUTOXYCARBONYLAMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID is employed as a starting material in the synthesis of bioactive compounds. Its ability to be easily modified and incorporated into larger molecular structures makes it a valuable resource for the development of new therapeutic agents and other biologically active substances.
Check Digit Verification of cas no
The CAS Registry Mumber 182287-49-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,2,2,8 and 7 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 182287-49:
(8*1)+(7*8)+(6*2)+(5*2)+(4*8)+(3*7)+(2*4)+(1*9)=156
156 % 10 = 6
So 182287-49-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H21NO5/c1-12(2,3)18-11(16)13-9(10(14)15)8-4-6-17-7-5-8/h8-9H,4-7H2,1-3H3,(H,13,16)(H,14,15)
182287-49-6Relevant academic research and scientific papers
AMIDE COMPOUND
-
, (2016/08/17)
The present invention relates to compound (I) or a salt thereof which has a RORγt inhibitory action. In the formula (I), each symbol is as defined in the specification.
SUBSTITUTED HETEROCYCLIC ACETAMIDES AS KAPPA OPIOID RECEPTOR (KOR) AGONISTS
-
Page/Page column 111, (2013/09/26)
The present invention relates to a series of substituted compounds having the general formula (I), including their ste reoisomers and/or their pharmaceutically acceptable salts, wherein R1, R2, R3. R4, R5, and R6 are as defined herein. This invention also relates to methods of making these compounds including intermediates. The compounds of this invention are effective at the kappa (κ) opioid receptor (KOR) site. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic pain, and associated disorders, particularly functioning peripherally at the CNS.
